April 23, 2026 AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder
April 23, 2026 FDA recall highlights ongoing safety risks from illegal “gel removers,” says Nail Manufacturer Council on Safety
